Altered body composition and fuel metabolism in stable kidney transplant patients on immuno‐suppressive monotherapy with cyclosporine A

. Glucocorticoid associated altered body fat distribution and muscle wasting are well known following kidney grafting. Whether an immunosuppressive regimen after glucocorticoid withdrawal (i.e. monotherapy with cyclosporine A (CsA)) is associated with normalization of altered body fat distribution and muscle mass remains to be determined. Therefore 18 renal transplant patients (nine males and nine females, 64 ± 5 (mean ± SEM) months since transplantation; CsA-monotherapy: 38 ± 7 months) and 18 age, sex and body mass index matched healthy volunteers were investigated using indirect calorimetry and dual energy X-ray absorptiometry. Lean body mass (LBM) was decreased in patients mostly due to loss of striated muscle in the legs (P<0·01), Compared to healthy controls, fat mass was increased in head and trunk (P<0·01) and similar in extremities. Resting energy expenditure expressed per kg LBM was increased by more than 10% (P<0·05) in patients vs. controls. Plasma insulin and glucose concentrations, total serum cholesterol (C), triglyceride levels and the ratio of LDL-C to HDL-C were all elevated (P<0·01) in patients as compared with controls. In summary, renal transplant patients on immunosuppressive mono therapy with CsA demonstrate decreased muscle mass despite discontinuation of prednisone therapy. The increased upper body fat might account, at least in part, for peripheral hyperinsulinaemia and dyslipidaemia observed in kidney transplant patients even years after successful transplantation.